Tag: Molnupiravir

spot_img

Molnupiravir becomes the first Oral Antiviral Drug to be included in WHO’s living Guidelines on COVID-19 Therapeutics 

WHO has updated its living guidelines on COVID-19 therapeutics. The ninth update released on 03 March 2022 include a conditional recommendation on molnupiravir.  Molnupiravir has...

Could Merck’s Molnupiravir and Pfizer’s Paxlovid, the Two New Anti-Viral Drugs Against COVID-19 Hasten the End of the Pandemic?

Molnupiravir, the world’s first oral drug (approved by MHRA, UK) against COVID-19 along with upcoming drugs such as Paxlovid and sustained vaccination drive has raised hopes...

Molnupiravir: A Game Changing Oral Pill for Treatment of COVID-19

Molnupiravir, a nucleoside analog of cytidine, a drug that has shown excellent oral bioavailability and promising results in Phase 1 and Phase 2 trials, could prove...

Stay in touch:

86,344FansLike
41,696FollowersFollow
1,772FollowersFollow
49SubscribersSubscribe

Newsletter

Don't miss

Daraxonrasib Approved for Pancreatic Cancer

Daraxonrasib (Rasonque by Revolution Medicines, Inc.), an inhibitor of...

Glacial Collapse Led to Seismic Event in Nepal 

The magnitude 5.2 seismic event recorded near the border...

Significance of Nancy Grace Roman Space Telescope

Nancy Grace Roman Space Telescope (commonly referred to as...

NASA Invites ISRO to Join Moon Base Programme

NASA has invited ISRO (Indian Space Research Organisation) to...

2026 Total Solar Eclipse

On 12 August 2026, a total solar eclipse was...